NAD IV Therapy in Dubai 2026: Real Costs (AED 399–2,500), Provider Comparison & What the Evidence Actually Says

You’re paying AED 399 at one clinic and AED 2,500 at another for the exact same molecule in the exact same bag. NAD+ IV therapy is Dubai’s priciest wellness flex — and the gap between what clinics charge and what the evidence actually supports is wider than the price gap.

I’ve tracked this market since early 2025, watched the provider count triple, and read every clinical trial that exists for intravenous NAD+. Here’s the uncomfortable summary: there are zero randomized controlled trials of IV NAD+ in healthy humans. The largest human study enrolled eight people. The most rigorous 2026 systematic review calls the evidence “insufficient to support routine clinical or wellness use.”

None of that means the treatment is worthless. It means you’re paying for a biological hypothesis, not a proven therapy. This guide gives you every published price in Dubai, the actual evidence (what it shows and what it doesn’t), the regulatory reality, and a hard list of who should walk away.

What NAD+ Actually Does in Your Body

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It shuttles electrons in metabolic reactions — glycolysis, the citric acid cycle, oxidative phosphorylation. Without it, your mitochondria stop producing ATP. You die.

After age 40, circulating NAD+ levels drop roughly 30–50% compared to your 20s. That decline correlates with mitochondrial dysfunction, increased oxidative stress, and impaired DNA repair (NAD+ is a substrate for PARP enzymes and sirtuins). The theory: replenish NAD+ → restore mitochondrial function → slow aging, boost cognition, improve recovery.

The theory is solid. The delivery method is where it gets murky.

The Evidence Problem: What Studies Actually Show

I pulled every human study on IV NAD+ I could find. Here’s the full list — it’s short.

Braidy et al. (2018) — The “Largest” Trial

Eight healthy adults aged 70–80. Open-label, no control group. 1,000 mg IV NAD+ daily for six consecutive days. Results: reduced oxidative stress markers (8-iso-prostaglandin F2α, protein carbonyls), lower inflammatory cytokines (CRP, IL-6), increased SIRT1/FOXO1 expression. Published in a peer-reviewed journal. No placebo. No blinding. n=8.

PMC12907335 (2025) — NAD+ vs NR Head-to-Head

Retrospective chart review from a commercial wellness clinic. Participants got 500 mg NAD+ IV or NR IV over four consecutive days, with 30-day follow-up. NAD+ group reported moderate-to-severe GI symptoms, increased heart rate, and chest pressure during infusions. No significant changes in liver enzymes, hsCRP, BUN/creatinine, or TSH. Alkaline phosphatase dropped slightly (stayed in normal range). Translation: it’s biologically active but the clinical endpoints moved nowhere.

PMC13601825 (2026) — The Definitive Narrative Review

This is the paper that should end the marketing hype. Their conclusion, verbatim: “Current evidence regarding IV NAD+ therapy remains preliminary and insufficient to support routine clinical or wellness use.” They note that all available human data come from “small uncontrolled studies, observational investigations, and isolated case reports.” No RCTs exist. Period.

What Oral Precursors Show (for comparison)

NMN and NR (oral NAD+ precursors) have larger trials — Yi et al., Igarashi et al., Fukamizu et al. — showing safety and NAD+ target engagement in middle-aged/older adults, with “variable but suggestive effects on physical performance, walking speed, and sleep quality” (Springer, Mol Biol Rep 2026). Still no proof of anti-aging in humans. But the evidence base is an order of magnitude larger than what IV has.

The honest take: IV NAD+ raises your blood NAD+ level for a few hours. Whether that translates to feeling better, thinking clearer, or aging slower has not been demonstrated in any controlled trial. You’re paying AED 400–5,000 for a pharmacokinetic fact, not a clinical outcome.

What NAD+ actually does — and why clinics charge AED 2,500 for it

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It shuttles energy inside mitochondria and feeds the enzymes that repair DNA. Your levels fall with age — by middle age you carry roughly half what you did at 20 — and that decline is real biochemistry, published in peer-reviewed journals.

That’s where the science stops and the pricing menu starts. The leap from “NAD+ levels drop with age” to “a 90-minute drip reverses your biological age” has never been demonstrated in a controlled human trial. Not once.

Here’s everything that actually exists, as of October 2026:

• An 8-person pilot (Braidy, 2018). Eight healthy adults aged 70–80 received 1,000 mg IV NAD+ daily for six days. Oxidative-stress markers fell, SIRT1 and FOXO1 expression rose. No control group. Eight people. This is still cited as the landmark IV study.
• A 2026 commercial-clinic retrospective (PMC12907335). Clients at a US wellness clinic got 500 mg NAD+ IV or NR IV over four consecutive days, with 30-day follow-up. NAD+ recipients reported moderate-to-severe GI symptoms, raised heart rate, and chest pressure during infusions. Liver enzymes and inflammation markers didn’t move. It’s the most rigorous head-to-head that exists — and it’s a chart review, not a trial.
• A 2026 narrative review (PMC13601825) that says it plainly: “Randomized placebo-controlled trials specifically evaluating IV NAD+ administration are currently lacking.” The authors conclude the evidence is “insufficient to support routine clinical or wellness use.”
• A critical review in Acta Dermatovenerologica APA (2026) graded IV longevity therapies the same way: small uncontrolled studies, no validated aging biomarkers, placebo-controlled trials scarce or conflicting.

Notice what’s missing from that list. Nobody has measured whether you feel better, think faster, or live longer. Those outcome trials don’t exist.

NAD IV price comparison: every Dubai provider we checked (October 2026)

The spread is absurd for the same molecule at the same dose. We pulled every published menu we could find:

Provider	Dose	Price per session (AED)	Home option	Physician oversight
JPR Home Healthcare (Silicon Oasis)	100 mg	399 (promo, list 599)	Yes	Not stated
MSC Dubai (Al Barsha / Al Mina)	100 mg	599	Clinic only	Yes
DioLife Health	100 mg	520 (list 750)	Yes	DHA-certified team
Halcyon Aesthetics (Jumeirah)	100 mg	599	No	Yes
DCDC Dubai Healthcare City	From 250 mg	From 799	Yes	Required — physician-prescribed
BestDOC (home service)	250 mg	799	Yes	Yes
The Protocols Company / UAE Peptide Clinic (Dubai Hills)	100–500 mg	1,061–3,245	Yes	Independent physician review
Aafiyah Care (Business Bay)	250 mg	1,499	Yes	Longevity consult required
Dynamic Clinic	250 mg	1,800–2,500	Varies	Yes
Aster / myAster (home)	250 mg	900–2,500	Yes	Yes
HSMC Abu Dhabi	—	1,500 (3 sessions: 3,600 / 6 sessions: 6,000)	No	Yes

Read that table again. A 250 mg bag — the most common dose on Dubai menus — runs from AED 399 to AED 2,500 depending on who’s holding the cannula. Bellora’s market survey (12 October 2026) puts the published 250 mg band at AED 799–2,500, 500 mg at AED 1,000–2,500, and one 500 mg “recovery protocol” at up to AED 7,000. HMS Mirdif’s 100 mg at AED 500 is the cheapest published bag they found.

Prices above are as printed on clinic pages in October 2026 and change without notice. Most don’t state whether VAT is included, and home visits typically add AED 100–250. This article names and prices paid providers for comparison only — nothing here is an endorsement.

Who should not get an NAD IV — the honest safety list

There’s no standardized contraindication list for IV NAD+, which is itself the problem. But based on the PMC12907335 study’s exclusion criteria, informed-consent protocols used at IV clinics, and the 2026 narrative review, responsible providers screen out:

• Pregnant or breastfeeding women. Zero safety data. Every serious provider declines.
• Active cancer or recent cancer history. NAD+ feeds PARP enzymes — the ones tumors use to repair their own DNA. It can theoretically protect cancer cells and blunt chemotherapy or PARP-inhibitor treatment.
• Severe heart or kidney disease. Fluid load plus infusion reactions are the risk; the commercial-clinic study logged raised heart rate and chest pressure even in healthy clients.
• People on warfarin or other anticoagulants without close INR monitoring — NAD+ can interfere with clotting-factor metabolism.
• G6PD deficiency and thalassemia. Unstudied in these groups; most protocols exclude them.
• Uncontrolled hypertension or unstable cardiac symptoms. NAD+ causes vasodilation — blood pressure can drop during the drip.

The most common in-chair effects are nausea, flushing, chest pressure, and cramping — usually rate-dependent, meaning a slower drip fixes them. If a clinic doesn’t take a medical history before hooking you up, that’s your cue to walk out.

The regulation gap: Dubai doesn’t have an NAD+ rule

I went looking for a DHA circular that specifically addresses NAD+ drips. There isn’t one. Here’s how the regulatory picture actually works:

• Any facility giving IV drips must hold a DHA facility license under the Manual for Licensing Health Facilities (DHA/HRS/HLD/MA-1, 2024 edition), with applications routed through the Sheryan system.
• The professionals administering must be individually DHA-licensed — Executive Council Resolution No. 49 of 2024 and Administrative Resolution No. 25 of 2025 govern this.
• But the specific indication — “anti-aging,” “wellness,” “biohacking” — is unregulated. The molecule itself has no approved therapeutic indication in the UAE.

Bellora’s October 2026 survey adds a useful comparison: Abu Dhabi’s DoH rates IV NAD+ as not currently applicable in a licensed longevity-clinic setting. The same drip is graded differently 130 km away. Worth knowing before you book across the border.

Practical checks before you pay: look up the clinic on the DHA public facility register, ask whether a physician reviews your history before the drip, and ask what emergency protocol exists if you react mid-infusion. Vague answers on any of those three? That’s a no.

What actually works instead (or alongside)

If the evidence gap bothers you — it should — here’s what the same money buys with stronger data behind it:

• Oral NMN or NR (AED 150–400/month). Larger trials, longer follow-up, same NAD+ pathway. Yi et al. and Igarashi et al. showed safety and target engagement in middle-aged adults. Not proven anti-aging either, but the pharmacokinetics are better characterized than IV.
• Sleep optimization. NAD+ synthesis follows circadian rhythm. Fix your sleep before you fix your coenzymes.
• Exercise. Upregulates NAMPT (the rate-limiting enzyme in NAD+ salvage) more reliably than any infusion. Free.
• If you still want the IV: do one session at the lowest dose (100–250 mg) from a physician-supervised provider. Track how you feel for 7 days. If nothing changes — and the literature says it probably won’t — you’ve saved yourself AED 5,000+ on a “loading protocol.”

For a broader look at Dubai’s IV wellness market, our IV Drip Therapy evidence review covers the full landscape — vitamin drips, glutathione, and where NAD+ fits in the hierarchy of what’s actually supported.

FAQ: NAD IV Therapy in Dubai

How much does NAD IV therapy cost in Dubai?

Published 2026 menus range from AED 399 (100 mg at JPR Home Healthcare) to AED 2,500 (250 mg at Aster’s home platform). The most common 250 mg dose runs AED 799–2,500 depending on provider. Home visits add AED 100–250. Multi-session packages (3–6 sessions) typically reduce per-session cost by 15–25%.

Does NAD IV therapy actually work for anti-aging?

No randomized controlled trial has demonstrated anti-aging, cognitive, or energy benefits from IV NAD+ in healthy humans. The largest study enrolled 8 people with no control group. A 2026 systematic review (PMC13601825) concluded the evidence is “insufficient to support routine clinical or wellness use.” IV NAD+ reliably raises blood NAD+ levels temporarily — whether that translates to measurable benefit is unproven.

Is NAD IV therapy legal in Dubai?

There is no DHA circular specifically addressing NAD+ drips. Any facility administering IV therapy must hold a DHA facility license (Manual for Licensing Health Facilities, 2024 edition) and use DHA-licensed professionals. The “anti-aging” or “wellness” indication itself is unregulated. Abu Dhabi’s DoH rates IV NAD+ as not currently applicable in licensed longevity clinics.

Who should NOT get NAD IV therapy?

Pregnant or breastfeeding women, anyone with active or recent cancer (NAD+ feeds PARP-mediated DNA repair in tumors), severe heart or kidney disease, uncontrolled hypertension, G6PD deficiency, thalassemia, and people on warfarin without close INR monitoring. If a clinic doesn’t take a medical history before the drip, leave.

How long does an NAD IV session take?

100 mg takes roughly 45–60 minutes. 250 mg runs 60–120 minutes. 500 mg can take 2–3 hours. 1,000 mg protocols run 4–5 hours. The infusion must be slow — rapid administration causes nausea, chest pressure, and flushing.

What to do now

If you’re still curious after reading the evidence: book a single 100 mg or 250 mg session at a physician-supervised clinic (DCDC at AED 799 or MSC at AED 599 are the cheapest medically overseen options). Go in with a baseline — note your sleep quality, energy, and focus for the week before. Compare the week after. If nothing shifts, you have your answer without spending AED 9,999 on a “loading protocol.”

If you’ve already done NAD+ IV in Dubai, the comments section is open — what did you actually notice? Real experience data beats marketing copy every time.

Disclosure: This article names specific clinics and prices for comparison purposes only. We receive no commission from any provider mentioned. Prices verified October 2026 and subject to change.

This content is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any IV therapy or wellness protocol. Last updated: October 2026.